China
Africa
Explore chapters and articles related to this topic
Menopause: a modern perspective from a controversial history
Published in Barry G. Wren, Progress in the Management of the Menopause, 2020
This is a record of phenomenal growth and development. The events leading to that first meeting, the establishment of the International Menopause Society (IMS), the journal Maluri las, the evolution of research and health care relating to the menopause, and the future role of the IMS within that context are the topics covered by this paper. Above all, I stand before you as the outgoing IMS President to pay tribute to the memory of Pieter van Keep, to recall some special moments during our years of close friendship, and to challenge you all to continue the dreams we developed almost 25 years ago.
Sleep Disturbances and Menopause
Published in Zippi Dolev, Mordechai Zalesch, Judy Kupferman, Sleep and Women's Health, 2019
Zippi Dolev, Mordechai Zalesch, Judy Kupferman
In 1985, members of the International Menopause Society met in France and formulated a milder opinion: “Menopause occurs around the age of 51 and presents a transition period from a state of fertility to a state of infertility.” This definition aroused disagreement among many in the medical community, who saw it as too simplistic and lacking the tragic dimension. Prominent among them was the American gynecologist, Wulf Utian, who claimed that menopause is endocrinopathy (glandular disease). A study conducted in 1986 in a menopause clinic in a general hospital in Los Angeles found that 53% of the women considered menopause to indeed constitute a medical problem that requires medical intervention.
Menopause and complementary and integrative medicine
Published in Jon Adams, Amie Steel, Alex Broom, Jane Frawley, Women’s Health and Complementary and Integrative Medicine, 2018
Wenbo Peng, David Sibbritt, Amie Steel, Holger Cramer, Jon Adams
The two wider menopause guidelines, including information on CIM use, are the position statements of the International Menopause Society in 2016 (Baber et al. 2016) and the American Association of Clinical Endocrinologists and American College of Endocrinology in 2017 (Cobin and Goodman 2017), respectively. The former guidelines state that high-quality findings from studies of CIM treatments (e.g. herbal medicines, acupuncture, meditation, and cognitive behavioral therapy) for menopausal symptoms are limited, and systematic reviews and meta-analyses show inconsistent and variable efficacy results. As such, no practice recommendations are provided for CIM. In contrast, the latter guidelines report that the wider non-hormonal therapies are supported and recommended for the management of menopausal symptoms but provide no further details (Cobin and Goodman 2017).
A life devoted to the global care of women
Published in Climacteric, 2023
Manel was the first introducing the contraceptive pill in Portugal in the sixties and in 1967 founded the Portuguese Contraception Society. Moreover, his interest in steroids led him to introduce new hormone measurement methods, which allowed her to start new ovulation stimulation treatments, with human gonadotropins and daily hormonal monitoring of stimulated cycles and in 1975 he created the Portuguese Society of Reproductive Medicine – later affiliated to the International Federation of Fertility Societies. In short, all topics included in the field of reproductive endocrinology was a focus of his interest and menopause was the main target. In 1978 took part in the constitution of the International Menopause Society, being board member until 2006 and one of the promoters of the celebration of the World Menopause Day. In 1995 founded the Portuguese Menopause Society and in 1998 founded with Martin Birkhauser the European Menopause and Andropause Society.
Update on bone health: the International Menopause Society White Paper 2021
Published in Climacteric, 2021
T. J. de Villiers, S. R. Goldstein
The Board of the International Menopause Society (IMS) has decided to focus on bone health for World Menopause Day 2021. Osteoporosis and associated fractures are the most common chronic metabolic bone disease and represent a major global health problem, contributing to 8.9 million fractures worldwide on an annual basis [1]. Worldwide, there are marked variations in the rates of hip fracture and major osteoporotic fractures [2]. Fractures associated with osteoporosis cause not only increased morbidity but also an increased mortality [3]. A special issue of Climacteric dealing in great depth with all aspects of bone health will appear early next year. The first part of the present paper deals with demystifying key clinical aspects of osteoporosis, namely definition, fracture risk prediction, stratification of risk, intervention thresholds and the integration of these factors into clinical practice. The second part of the paper deals with the emerging recognition of the role of muscle strength and function in maintaining bone health.
Effects of different menopausal hormone replacement regimens on body composition in Chinese women
Published in Climacteric, 2018
Y. Deng, W. Xue, Y. Wang, S. Zhu, X. Ma, A. Sun
Menopause is characterized by important changes in hormonal status that exert significant effects on body composition1. The menopausal transition is associated with increased central body fat distribution and decreased lean muscle mass2,3, with hormonal factors constituting one of the contributors to these body composition changes4. It has been hypothesized that menopausal hormone therapy (MHT) may help counter these changes in body composition among postmenopausal women, and several large clinical trials have explored the effect of MHT on body composition5–8; however, their conclusions were inconsistent. Guidelines from the International Menopause Society recommended that hormone replacement therapy (HRT) for postmenopausal women should be the lowest effective dose and individualized for each woman, and that different types of progestogens may have different health outcomes9. Several studies have shown that menopausal HRT can preserve lean body mass shortly after the menopausal transition10–12, but few of these clinical trials compared the effects of different doses of estrogen or different types of progestins on body composition. In addition, there is relatively little information in the literature regarding the effects of MHT on body composition in postmenopausal women in China. Therefore, the aim of this study was to compare the impact of different MHT regimens on body composition in healthy postmenopausal Chinese women.